Eczema Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the eczema market?
Recent years have seen substantial growth in the eczema market size. Projected growth suggests an increase from $16.41 billion in 2024 to $17.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.5%. The growth witnessed in the historical period can be tied back to factors such as the increased prevalence of autoimmune diseases, a surge in eczema cases, more approvals from authoritative bodies, a rise in air pollution incidents, and an escalated burden of allergic reactions.
What will be the eczema market size in the future?
The market size for eczema is projected to experience robust expansion in the upcoming years, escalating to $24.35 billion by 2029 with a compound annual growth rate (CAGR) of 8.1%. The surge in the predicted period is associated with various factors such as the amplified demand for atopic dermatitis treatment, heightened operational tasks, burgeoning awareness about eczema, the growing utilization of biologics, and the rise in utilization of telemedicine platforms. Key trends anticipated during the forecast period encompass strategic alliances, emerging treatments, injectable medications, and individualized medicine.
Get your eczema market report here!
https://www.thebusinessresearchcompany.com/report/eczema-global-market-report
What main drivers are fueling expansion in the eczema market?
The escalating incidence of autoimmune disorders is anticipated to fuel the expansion of the eczema market in the future. Autoimmune disorders are conditions where the body’s immune system erroneously attacks its own healthy cells, tissues, or organs, resulting in inflammation and damage. The rising incidence of such disorders can be traced back to genetic predisposition, environmental factors, infections, changes in diet, and lifestyle factors like stress and exposure to pollutants. Autoimmune illnesses like psoriasis, lupus, and rheumatoid arthritis are associated with disordered immune responses, leaving individuals more prone to eczema and other inflammatory skin conditions. For example, according to Versorgungsatlas.de, a Germany-based organization, in 2022, 6,304,340 of the 73,241,305 insured individuals were diagnosed with at least one autoimmune disease, manifesting a raw prevalence rate of 8.61%. Hence, the escalated incidence of autoimmune disorders is steering the growth of the eczema market.
What key areas define the segmentation of the global eczema market?
The eczema market covered in this report is segmented –
1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types
2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy
3) By Age Group: Children, Adults, Elderly
4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies
Subsegments:
1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies
2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses
3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors
4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21179&type=smp
Who are the dominant players expanding their reach in the eczema market?
Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc
What key trends are currently impacting the eczema market’s development?
Key players in the eczema market are prioritizing the development of novel products, such as eczema care creams, to improve treatment outcomes and satisfy the need for advanced skin care solutions from consumers. Eczema care creams are specifically formulated skincare products that moisturize, soothe, and shield eczema-affected skin, aiding in the reduction of itching, inflammation, and dryness. In September 2024, Dove, a personal care brand headquartered in the UK, introduced their new Eczema Care line for babies, featuring the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. Providing several exclusive features designed specifically for babies combating eczema, the Baby Dove Eczema Care line has products enriched with 100% skin-natural nourishing elements, ensuring their mildness for sensitive skin. Additionally, they include colloidal oatmeal (1.0%) as a critical ingredient for alleviating irritation and preserving moisture levels.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21179
Which regions are emerging as leaders in the eczema market?
North America was the largest region in the eczema market in 2024. The regions covered in the eczema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2025
Chronic Myeloid Leukemia Treatment Global Market Report 2025
Duchenne Muscular Dystrophy Global Market Report 2025
https://thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
